Diane-Laure Pagés
Co-founder & COO, Orakl Oncology
Diane-Laure Pagés is listed as Co-founder & COO, Orakl Oncology. Diane-Laure is scheduled to speak at Slush 2026 on 19 November 2026.
Compiled from published conference agendas; not yet confirmed by Diane-Laure. Is this you? Claim this profile.
About
Diane-Laure Pagès is the co-founder and COO of Orakl Oncology, a French techbio company building an AI-native platform that predicts how cancer drugs will perform in patients. Orakl spun out of Gustave Roussy, one of Europe’s leading cancer centres, in 2023. It combines tumour avatars grown from patient samples with clinical data and machine learning, so that drug developers can de-risk their programmes. As COO, Diane-Laure runs operations, legal and people, and leads the hospital partnerships that give Orakl access to patient tumour samples and matched clinical data. An engineer by training, she is a graduate of École polytechnique and holds a PhD in biology from Gustave Roussy. Orakl raised €11M in December 2024 to launch its first products, O-Predict and O-Validate.
Upcoming
Slush 2026 18 November 2026 – 19 November 2026
- Clinical Operations Speaker · 19 November 2026
Spoke alongside
People who have shared a session with Diane-Laure at events on B2DB.
- Brad Treeby Co-founder & CEO · NeuroHarmonics 1 shared session
- Dr. Sonia Szamocki Founder & CEO · 01Health 1 shared session
- Rachel Finegold Founder & CEO · Frontier Health 1 shared session
- Sami Marttinen Co-founder & CEO · Treat 1 shared session
Others from Orakl Oncology
- Fanny Jaulin CEO & Cofounder 2 sessions
- Gustave Ronteix Co-Founder and CTO 2 sessions